Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential Applications of NRF2 Modulators in Cancer Therapy
Emiliano Panieri, Aleksandra Buha Djordjević, Pelin Telkoparan‐Akillilar, et al.
Antioxidants (2020) Vol. 9, Iss. 3, pp. 193-193
Open Access | Times Cited: 130

Showing 1-25 of 130 citing articles:

SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression
Rúbens Cecchini, Alessandra Lourenço Cecchini
Medical Hypotheses (2020) Vol. 143, pp. 110102-110102
Open Access | Times Cited: 357
Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
Małgorzata Szczuko, Justyna Kikut, Urszula Szczuko, et al.
Nutrients (2021) Vol. 13, Iss. 7, pp. 2452-2452
Open Access | Times Cited: 112
Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer
Pelin Telkoparan‐Akillilar, Emiliano Panieri, Dilek Cevik, et al.
Molecules (2021) Vol. 26, Iss. 5, pp. 1417-1417
Open Access | Times Cited: 110
An update of Nrf2 activators and inhibitors in cancer prevention/promotion
Farhad Pouremamali, Amir Pouremamali, Mehdi Dadashpour, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 103
Ferroptosis‐modulating small molecules for targeting drug‐resistant cancer: Challenges and opportunities in manipulating redox signaling
Solveigh C. Koeberle, Anna P. Kipp, Hermann Stuppner, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 3, pp. 614-682
Open Access | Times Cited: 54
The Multifaceted Roles of NRF2 in Cancer: Friend or Foe?
Christophe Glorieux, Cinthya Enríquez, Constanza Díaz González, et al.
Antioxidants (2024) Vol. 13, Iss. 1, pp. 70-70
Open Access | Times Cited: 29
Nanomaterials‐Induced Redox Imbalance: Challenged and Opportunities for Nanomaterials in Cancer Therapy
Xumeng Wu, Ziqi Zhou, Kai Li, et al.
Advanced Science (2024) Vol. 11, Iss. 16
Open Access | Times Cited: 27
5-Methylcytosine transferase NSUN2 drives NRF2-mediated ferroptosis resistance in non-small cell lung cancer
Youming Chen, Zuli Jiang, Chenxing Zhang, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 4, pp. 106793-106793
Open Access | Times Cited: 18
Emerging role of NRF2 in ROS-mediated tumor chemoresistance
Danfeng Xue, Xiongming Zhou, Jiaxuan Qiu
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110676-110676
Open Access | Times Cited: 137
Crocin: A fighter against inflammation and pain
Mahmoud Hashemzaei, Charalampos Mamoulakis, Konstantinos Tsarouhas, et al.
Food and Chemical Toxicology (2020) Vol. 143, pp. 111521-111521
Closed Access | Times Cited: 94
Synthesis and Anticancer Activity of CDDO and CDDO-Me, Two Derivatives of Natural Triterpenoids
Rebecca Borella, Luca Forti, Lara Gibellini, et al.
Molecules (2019) Vol. 24, Iss. 22, pp. 4097-4097
Open Access | Times Cited: 82
Analysis of the intricate effects of polyunsaturated fatty acids and polyphenols on inflammatory pathways in health and disease
Denisa Margină, Anca Ungurianu, Carmen Purdel, et al.
Food and Chemical Toxicology (2020) Vol. 143, pp. 111558-111558
Open Access | Times Cited: 73
Oroxylin A reduces osteoclast formation and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation
Yansi Xian, Yuangang Su, Jiamin Liang, et al.
Biochemical Pharmacology (2021) Vol. 193, pp. 114761-114761
Open Access | Times Cited: 67
Current methodologies to refine bioavailability, delivery, and therapeutic efficacy of plant flavonoids in cancer treatment
Cijo George Vazhappilly, Madumani Amararathna, Asha Caroline Cyril, et al.
The Journal of Nutritional Biochemistry (2021) Vol. 94, pp. 108623-108623
Closed Access | Times Cited: 61
New insights into the role of the Nrf2 signaling pathway in green tea catechin applications
Marjan Talebi, Mohsen Talebi, Tahereh Farkhondeh, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 6, pp. 3078-3112
Closed Access | Times Cited: 60
Natural Nrf2 Inhibitors: A Review of Their Potential for Cancer Treatment
Juan Zhang, Hong‐Xi Xu, Jiaqian Zhu, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 10, pp. 3029-3041
Open Access | Times Cited: 35
Dynamic Magneto-Softening of 3D Hydrogel Reverses Malignant Transformation of Cancer Cells and Enhances Drug Efficacy
Yufeng Shou, Xin Yong Teo, Xianlei Li, et al.
ACS Nano (2023) Vol. 17, Iss. 3, pp. 2851-2867
Closed Access | Times Cited: 31
Pyroptosis, ferroptosis, and autophagy cross-talk in glioblastoma opens up new avenues for glioblastoma treatment
Sicheng Wan, Guanghui Zhang, Ruochen Liu, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 31
New Insights Into the Anticancer Effects of p-Coumaric Acid: Focus on Colorectal Cancer
Wafâa Tehami, Abdelhafid Nani, Naim Akhtar Khan, et al.
Dose-Response (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 30
Inhibition of NRF2 enhances the acute myeloid leukemia cell death induced by venetoclax via the ferroptosis pathway
Xibao Yu, Yan Wang, Jiaxiong Tan, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 13
Nuclear factor erythroid 2-related factor 2 (Nrf2) signaling in heavy metals-induced oxidative stress
Swapnil Tripathi, Gitika B. Kharkwal, Rajeev Mishra, et al.
Heliyon (2024), pp. e37545-e37545
Open Access | Times Cited: 11
Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagus
Junsheng Fu, Zhaohui Xiong, Caizhi Huang, et al.
Journal of Biological Chemistry (2018) Vol. 294, Iss. 1, pp. 327-340
Open Access | Times Cited: 73
The NRF2/KEAP1 Axis in the Regulation of Tumor Metabolism: Mechanisms and Therapeutic Perspectives
Emiliano Panieri, Pelin Telkoparan‐Akillilar, Síbel Süzen, et al.
Biomolecules (2020) Vol. 10, Iss. 5, pp. 791-791
Open Access | Times Cited: 69
Molecular mechanism-based therapeutic properties of honey
Marjan Talebi, Mohsen Talebi, Tahereh Farkhondeh, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 130, pp. 110590-110590
Open Access | Times Cited: 69
Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies
Yunseo Woo, Hyo-Ji Lee, Young Mee Jung, et al.
Cells (2020) Vol. 9, Iss. 12, pp. 2709-2709
Open Access | Times Cited: 54
Page 1 - Next Page

Scroll to top